Skip to main content
. 2020 Apr 2;46(5):510–514. doi: 10.1111/nan.12613

Table 1.

CTNNB1 exon 3 sequencing analysis of DNA from 22 cases of ACP

Case No: Age at diagnosis (years)*

Tumour content

(% nuclear area)

DNA conc (copies/ul)

CTNNB1 mutation

by Tam‐Seq

CTNNB1 mutation

by Sanger Seq

Average mutation allele frequency
1 8 20 1100 T41I T41I 17%
2 14 70 2315 T41I T41I 28%
3 6 70 390 S37F No mutation 15%
4 14 60 1155 S45F Failed** 35%
5 8 10 525 S33F No mutation 3%
6 12 50 680 S37A No mutation 16%
7 46 70 770 T41I No mutation 21%
8 71 80 8854 T41I T41I 35%
9 adult 80 395 S33C S33C 39%
10 adult 80 2273 T41I T41I 29%
11 60 70 143 T41I T41I 15%
12 83 45 2087 S33C S33C 19%
13 22 80 439 T41I T41I 26%
14 87 90 1573 D32N D32N 31%
15 61 50 195 S33C S33C 30%
16 65 40 237 T41A T41A 25%
17 53 40 520 S37A S37A 17%
18 adult 90 470 I35S Failed** 43%
19 adult 60 260 S33F No mutation 25%
20 adult 25 1256 S37F No mutation 3%
21 adult 20 1460 S33F No mutation 18%
22 adult 70 4505 S37C Failed** 47%
*

Age not available in all patients.

**

Sanger sequencing reaction failed to give readable trace.